A surprisingly high frequency of HPV-specific CD4+ T-cell responses in women with cervical carcinoma compared to those with high-grade CIN has also been observed in a similar study published recently by de Jong et al (2004). The gene discussed is CD4; the disease is cervical carcinoma.